Duodenal neuroendocrine tumors
Conditions
Interventions
None listed
Sponsors
Chiba Cancer Center, Endoscopy Division, Mamoru Tokunaga
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with duodenal neuroendocrine tumors who underwent endoscopic resection at each institution between January 2012 and July 2024
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcomes of endoscopic resection | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical courses after endoscopic resection | — |
Countries
Japan
Contacts
Public ContactMAMORU TOKUNAGA
Chiba Cancer Center Endoscopy Division
Outcome results
None listed